 4D pharma PLC AIM:DDD, NASDAQ:LBPS has announced the appointment of John Doyle as chief financial officer. The pharmaceutical company, which specialises in the development of live biotherapeutic products, says Doyle will become a member of the management team, bringing with him over 15 years of experience. 